Jyong Biotech Ltd. Ordinary Shares

NASDAQ:MENS

Biotechnology

Healthcare
$1.86 -1.41%

-$0.02 today

Market cap
$141.41M
Beta
2.08
P/E (TTM)
-25.1
EPS (TTM)
-$0.06
52W Low $1.43High $67.00

Volume 0.07M

Average 0.10M

Balance Sheet

Inspect the capital base behind the business.

Assets

$20.78M

FY 2025 · Annual

+226.4% YoY

Liabilities

$45.68M

FY 2025 · Annual

+6.5% YoY

Equity

-$24.91M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents551K718K177K98K1.18M
Short-term Investments1.83M94K000
Net Receivables000013.51M
Inventory00000
Other Current Assets263K1.65M1.66M108K854K
Total Current Assets2.65M2.46M1.84M206K15.54M
Property, Plant & Equipment (Net)6.78M6M3.54M3.19M5.23M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets8K283K2.87M2.97M6K
Total Non-current Assets6.78M6.28M6.41M6.16M5.24M
Total Assets9.43M8.75M8.25M6.37M20.78M
Account Payables46K4K2K3K2K
Short-term Debt4.93M7.65M7.97M7.28M8.36M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities23K4.22M4.99M3.33M26.31M
Total Current Liabilities6.29M12.91M14.26M12.13M34.81M
Long-term Debt6.26M6.32M8.52M10.68M10.16M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities19.86M19.04M19.47M20.06M688K
Total Non-current Liabilities26.46M25.47M28.06M30.76M10.87M
Total Liabilities32.76M38.38M42.32M42.89M45.68M
Common Stock1K1K1K1K1K
Retained Earnings(19.03M)(25.66M)(30.06M)(33.08M)(37.75M)
Accumulated OCI266K590K548K1.12M682K
Other Stockholders Equity00000
Minority Interest00000
Total Equity(23.33M)(29.63M)(34.07M)(36.52M)(24.91M)
Total Debt11.79M14.25M16.69M18.14M18.55M
Net Debt11.24M13.53M16.51M18.04M17.37M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$1.2M
Receivables$13.5M
Other Current$854.0K
Total Current Assets$15.5M
PP&E (Net)$5.2M
Other Non-current$6.0K
Total Non-current Assets$5.2M
Total Assets$20.8M

Analysis

Selected assets total $20.8M for Latest. The largest visible component is Receivables at $13.5M, about 65.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
20-F20-F filingMay 15, 2026
NT 20-FNT 20-F filingApr 29, 2026
SC 13DSC 13D filingApr 24, 2026
3Initial statement of beneficial ownershipApr 14, 2026
3Initial statement of beneficial ownershipApr 8, 2026

How much cash does MENS have?

Jyong Biotech Ltd. Ordinary Shares (MENS) reported $1.18M in cash and equivalents in fiscal 2025.

How much debt does MENS carry?

Jyong Biotech Ltd. Ordinary Shares (MENS) reported $18.55M of total debt, with net debt of $17.37M.